In addition to the compounds clinically used for the treatment of nasopharyngeal carcinoma, FMN is also considered to be a therapeutically promising compound, which can achieve antiproliferative and invasive effects through effective inhibition of the oncogenic ERK1/2 pathway and the Lamin A/C signaling pathway, thereby modulating the nasopharyngeal carcinoma tumor microenvironment and inhibiting the migration and invasion of cancer cells (Ying et al., 2019). This evidence concerns the gene MAPK3 and nasopharyngeal carcinoma.